News & Updates

Patients with coronavirus disease-2019 (COVID-19) commonly present with headaches, loss of smell and taste, diarrhea, and breathing difficulties.

Clinically established temporomandibular joint (TMJ) involvement occurs frequently in adults with juvenile idiopathic arthritis (JIA), which suggests the need for awareness of TMJ problems in this population, according to a study.

Patients with breast or gastrointestinal (GI) cancer who are being treated with capecitabine monotherapy may benefit from using topical diclofenac gel to prevent or reduce the incidence of hand-foot syndrome (HFS), a common side effect of some chemotherapy drugs, reports a recent study presented at ESMO 2023.

First-line treatment with TST001 (osemitamab) in combination with capecitabine and oxaliplatin (CAPOX) is safe and well tolerated in patients with advanced gastric/gastroesophageal junction (G/GEJ) cancer, according to a study presented at ESMO 2023.